Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation

Expert Reviews in Molecular Medicine

Volumn 13, Issue , 2011, Pages

  Dao Thi, Viet Loan ^a   Dreux, Marlène ^a   Cosset, François Loïc ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C1; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI; VERY LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR B;

ARTICLE; CHOLESTEROL TRANSPORT; HEPATITIS C; HUMAN; HUMORAL IMMUNITY; HYPERVARIABLE REGION 1; INTERNALIZATION; LIPID MEMBRANE; LIPID METABOLISM; LIPID RAFT; MEMBRANE FUSION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; CELL CULTURE; COMPLEMENTARITY DETERMINING REGION; HEPATITIS C VIRUS; METABOLISM; PHYSIOLOGY; REVIEW;

HEPATITIS C VIRUS;

ANIMALS; CELLS, CULTURED; COMPLEMENTARITY DETERMINING REGIONS; HEPACIVIRUS; HUMANS; SCAVENGER RECEPTORS, CLASS B; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 79956149806     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399411001785     Document Type: Article

References (170)

1. Shepard, C.W., Finelli, L. and Alter, M.J. (2005) Global epidemiology of hepatitis C virus infection. Lancet Infectious Disease 5, 558-567 (Pubitemid 41196755)
2. Lindenbach, B.D. and Rice, C.M. (2001) Flaviviridae: The Viruses and Their Replication. In Fields Virology, 5th Edn, (Knipe D.M. and Howley P.M., Eds), pp. 1101-1152, Lippincott Williams & Wilkins, Philadelphia, PA
3. Penin, F. et al. (2004) Structural biology of hepatitis C virus. Hepatology 39, 5-19 (Pubitemid 38461460)
4. Cocquerel, L. et al. (1999) The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum. Journal of Virology 73, 2641-2649 (Pubitemid 29135648)
5. Cocquerel, L. et al. (1998) A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. Journal of Virology 72, 2183-2191 (Pubitemid 28100775)
6. Cocquerel, L. et al. (2000) Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. Journal of Virology 74, 3623-3633 (Pubitemid 30180306)
7. Murray, C.L., Jones, C.T. and Rice, C.M. (2008) Architects of assembly: roles of Flaviviridae nonstructural proteins in virion morphogenesis. Nature Reviews. Microbiology 6, 699-708
8. Andre, P. et al. (2002) Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. Journal of Virology 76, 6919-6928 (Pubitemid 41246207)
9. Bradley, D. et al. (1991) Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. Journal of Medical Virology 34, 206-208
10. Hijikata, M. et al. (1993) Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. Journal of Virology 67, 1953-1958 (Pubitemid 23088368)
11. Nielsen, S.U. et al. (2006) Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. Journal of Virology 80, 2418-2428 (Pubitemid 43271547)
12. Thomssen, R. et al. (1992) Association of hepatitis C virus in human sera with beta-lipoprotein. Medical Microbiology and Immunology 181, 293-300
13. Felmlee, D.J. et al. Intravascular transfer contributes to postprandial increase in numbers of very-lowdensity hepatitis C virus particles. Gastroenterology 139, 1774-1783, 1783 e1771-1776
14. Burlone,M.E. and Budkowska,A. (2009)Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. Journal of General Virology 90, 1055-1070
15. Andre, P. et al. (2005) HepatitisCvirus particles and lipoprotein metabolism. Seminars in Liver Disease 25, 93-104
16. Icard, V. et al. (2009) Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS One 4, e4233
17. Bartenschlager, R. et al. (2011) Assembly of infectious hepatitis C virus particles. Trends in Microbiology 19, 95-103
18. Meunier, J.C. et al. (2008) Apolipoprotein c1 association with hepatitis C virus. Journal of Virology 82, 9647-9656
19. Maillard, P. et al. (2006) The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. FASEB Journal 20, 735-737 (Pubitemid 46671198)
20. Prince, A.M. et al. (1996)Visualization of hepatitisC virions and putative defective interfering particles isolated from low-density lipoproteins. Journal of Viral Hepatitis 3, 11-17 (Pubitemid 126734193)
21. Agnello, V. et al. (1999) Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proceedings of the National Academy of Sciences of the United States of America 96, 12766-12771 (Pubitemid 29513577)
22. Molina, S. et al. (2007) The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. Journal of Hepatology 46, 411-419 (Pubitemid 46201721)
23. Rumin, S. et al. (1999) Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. Journal of General Virology 80 (Pt 11), 3007-3018 (Pubitemid 29504674)
24. Fournier, C. et al. (1998) In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. Journal of General Virology 79 (Pt 10), 2367-2374 (Pubitemid 28464293)
25. Lindenbach, B.D. et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309, 623-626 (Pubitemid 41033648)
26. Wakita, T. et al. (2005) Production of infectious hepatitisCvirus in tissue culture from a cloned viral genome. Nature Medicine 11, 791-796 (Pubitemid 41021213)
27. Zhong, J. et al. (2005) Robust hepatitis C virus infection in vitro. Proceedings of the National Academy of Sciences of the United States of America 102, 9294-9299 (Pubitemid 40923557)
28. Bartosch, B., Dubuisson, J. and Cosset, F.L. (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. Journal of Experimental Medicine 197, 633-642 (Pubitemid 36314658)
29. Drummer, H.E., Maerz, A. and Poumbourios, P. (2003) Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Letters 546, 385-390 (Pubitemid 36782444)
30. Hsu, M. et al. (2003) Hepatitis Cvirus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proceedings of the National Academy of Sciences of the United States of America 100, 7271-7276 (Pubitemid 36706428)
31. Podevin, P. et al. (2010) Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology 139, 1355-1364
32. Yi, M. et al. (2007) Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell cultureinfectious intergenotypic chimeric hepatitis C virus. Journal of Virology 81, 629-638 (Pubitemid 46067890)
33. Gastaminza, P., Kapadia, S.B. and Chisari, F.V. (2006) Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. Journal of Virology 80, 11074-11081 (Pubitemid 44706548)
34. Bankwitz, D. et al. (2010) Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. Journal of Virology 84, 5751-5763
35. Grove, J. et al. (2008) Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. Journal of Virology 82, 12020-12029
36. Lindenbach, B.D. et al. (2006) Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proceedings of the National Academy of Sciences of the United States of America 103, 3805-3809 (Pubitemid 43376636)
37. Merz, A. et al. (2011) Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. Journal of Biological Chemistry 286, 3018-3032
38. Gastaminza, P. et al. (2008) Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. Journal of Virology 82, 2120-2129 (Pubitemid 351293514)
39. Chang, K.S. et al. (2007) Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. Journal of Virology 81, 13783-13793
40. Huang, H. et al. (2007) Hepatitis Cvirus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proceedings of theNational Academyof Sciences of the United States of America 104, 5848-5853 (Pubitemid 47175622)
41. Jiang, J. and Luo, G. (2009) Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. Journal of Virology 83, 12680-12691
42. Cun,W., Jiang, J. and Luo, G. (2010) The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus. Journal of Virology 84, 11532-11541
43. Hishiki, T. et al. (2010) Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. Journal of Virology 84, 12048-12057
44. Owen, D.M. et al. (2009) Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology 394, 99-108
45. Benga, W.J. et al. (2010) Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. Hepatology 51, 43-53
46. Lavillette, D. et al. (2006) Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with Liposomes. Journal of Biological Chemistry 281, 3909-3917 (Pubitemid 43847814)
47. Lavillette, D. et al. (2007) Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. Journal of Virology 81, 8752-8765 (Pubitemid 47242848)
48. Flint, M. et al. (2004) Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins. Journal of Virology 78, 6875-6882 (Pubitemid 38781525)
49. Bartosch, B. et al. (2005) An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and highdensity lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. Journal of Virology 79, 8217-8229 (Pubitemid 40853525)
50. Dreux, M. et al. (2007) The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. Journal of Biological Chemistry 282, 32357-32369 (Pubitemid 350106439)
51. Dreux, M. et al. (2006) High density lipoprotein inhibits hepatitis C virus neutralising antibodies by stimulating cell entry via activation of the scavenger receptor BI. Journal of Biological Chemistry 281, 18285-18295 (Pubitemid 44035485)
52. Voisset, C. et al. (2005) High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. Journal of Biological Chemistry 280, 7793-7799 (Pubitemid 40349673)
53. Meunier, J.C. et al. (2005) Evidence for crossgenotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proceedings of the National Academy of Sciences of the United States of America 102, 4560-4565
54. Cocquerel, L., Voisset, C. and Dubuisson, J. (2006) Hepatitis C virus entry: potential receptors and their biological functions. Journal of General Virology 87, 1075-1084
55. Bartosch, B. and Cosset, F.-L. (2006) Cell entry of hepatitis C virus. Virology 348, 1-12
56. Dubuisson, J., Helle, F. and Cocquerel, L. (2008) Early steps of the hepatitis C virus life cycle. Cellular Microbiology 10, 821-827 (Pubitemid 351386938)
57. von Hahn, T. and Rice, C.M. (2008) HepatitisCvirus entry. Journal of Biological Chemistry 283, 3689-3693
58. Barth, H. et al. (2006) Viral and cellular determinants of the hepatitis C virus envelopeheparan sulfate interaction. Journal of Virology 80, 10579-10590 (Pubitemid 44628904)
59. Scarselli, E. et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO Journal 21, 5017-5025
60. Pileri, P. et al. (1998) Binding of hepatitis C virus to CD81. Science 282, 938-941 (Pubitemid 28507525)
61. Evans, M.J. et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801-805 (Pubitemid 46582027)
62. Ploss, A. et al. (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882-886
63. Liu, S. et al. (2009) Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. Journal of Virology 83, 2011-2014
64. Blanchard, E. et al. (2006) Hepatitis C virus entry depends on clathrin-mediated endocytosis. Journal of Virology 80, 6964-6972 (Pubitemid 44025195)
65. Meertens, L., Bertaux, C. and Dragic, T. (2006) Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. Journal of Virology 80, 11571-11578 (Pubitemid 44788871)
66. Mee, C.J. et al. (2008) Effect of cell polarization on hepatitis C virus entry. Journal of Virology 82, 461-470 (Pubitemid 350309160)
67. Mee, C.J. et al. (2009) Polarization restricts hepatitis Cvirus entry into HepG2 hepatoma cells. Journal of Virology 83, 6211-6221
68. Reynolds, G.M. et al. (2008) Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology 47, 418-427 (Pubitemid 351280709)
69. Timpe, J.M. et al. (2008) Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47, 17-24 (Pubitemid 351171037)
70. Witteveldt, J. et al. (2009) CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. Journal of General Virology 90, 48-58
71. Brimacombe, C.L. et al. (2011) Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. Journal of Virology 85, 596-605
72. Bartosch, B. et al. (2003) Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. Journal of Biological Chemistry 278, 41624-41630 (Pubitemid 37310418)
73. Lavillette, D. et al. (2005) Characterization of hostrange and cell entry properties of hepatitis C virus of major genotypes and subtypes. Hepatology 41, 265-274 (Pubitemid 40173981)
74. Tscherne, D.M. et al. (2006) Time- and temperaturedependent activation of hepatitis C virus for lowpH- triggered entry. Journal of Virology 80, 1734-1741 (Pubitemid 43228714)
75. Kielian, M. and Rey, F.A. (2006) Virus membranefusion proteins: more than one way to make a hairpin. Nature Reviews. Microbiology 4, 67-76 (Pubitemid 43135288)
76. Calvo, D. and Vega, M.A. (1993) Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. Journal of Biological Chemistry 268, 18929-18935 (Pubitemid 23273842)
77. Webb, N.R. et al. (1998) SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. Journal of Biological Chemistry 273, 15241-15248 (Pubitemid 28272825)
78. Krieger,M. (2001) Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. Journal of Clinical Investigation 108, 793-797 (Pubitemid 32880286)
79. Van Eck, M. et al. (2008) Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo. Journal of Lipid Research 49, 136-146
80. Hoekstra,M. et al. (2009) Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production. Journal of Lipid Research 50, 1039-1046
81. Cai, L. et al. (2008) SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. Journal of Clinical Investigation 118, 364-375
82. Vishnyakova, T.G. et al. (2003) Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. Journal of Biological Chemistry 278, 22771-22780 (Pubitemid 36830338)
83. Saddar, S., Mineo, C. and Shaul, P.W. (2010) Signaling by the high-affinity HDL receptor scavenger receptor B type I. Arteriosclerosis, Thrombosis and Vascular Biology 30, 144-150
84. Silver, D.L. et al. (2001) High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. Journal of Biological Chemistry 276, 25287-25293
85. de la Llera-Moya, M. et al. (1999) Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. Journal of Lipid Research 40, 575-580 (Pubitemid 29116161)
86. Kellner-Weibel, G. et al. (2000) Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry 39, 221-229 (Pubitemid 30033337)
87. Parathath, S. et al. (2004) Changes in plasma membrane properties and phosphatidylcholine subspecies of insect Sf9 cells due to expression of scavenger receptor class B, type I, and CD36. Journal of Biological Chemistry 279, 41310-41318 (Pubitemid 39313570)
88. Zhang,Y. et al. (2007) Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovaryderived cells by protein kinase signaling pathways. Journal of Lipid Research 48, 405-416 (Pubitemid 46220607)
89. Barth, H. et al. (2005) Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes. Journal of Virology 79, 5774-5785 (Pubitemid 40548246)
90. Catanese, M.T. et al. (2007) High avidity monoclonal antibodies against human scavenger receptor class B type I efficiently block hepatitis C virus infection in the presence of HDL. Journal of Virology 81, 8063-8071 (Pubitemid 47101492)
91. Dreux, M. et al. (2009) Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. PLoS Pathogens 5, e1000310
92. Grove, J. et al. (2007) Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. Journal of Virology 81, 3162-3169 (Pubitemid 46456625)
93. Kapadia, S.B. et al. (2007) Initiation of HCV infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B Type I. Journal of Virology 81, 374-383 (Pubitemid 44975176)
94. Zeisel, M.B. et al. (2007) Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 46, 1722-1731
95. Gottwein, J.M. et al. (2009) Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49, 364-377
96. Catanese, M.T. et al. (2010) Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. Journal of Virology 84, 34-43
97. Regeard, M. et al. (2008) Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor. Journal of Viral Hepatitis 15, 865-870
98. Dhillon, S. et al. (2010) Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies. Journal of Virology 84, 5494-5507
99. Randall, G. et al. (2007) Cellular cofactors affecting hepatitis C virus infection and replication. Proceedings of theNational Academyof Sciences of the United States of America 104, 12884-12889 (Pubitemid 47255249)
100. Chroni, A. et al. (2005) SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. Biochemistry 44, 13132-13143
101. Li, X. et al. (2002) Reconstituted discoidal ApoEphospholipid particles are ligands for the scavenger receptor BI. The amino-terminal 1-165 domain of ApoE suffices for receptor binding. Journal of Biological Chemistry 277, 21149-21157 (Pubitemid 34952250)
102. Thuahnai, S.T. et al. (2003) A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins. Journal of Lipid Research 44, 1132-1142 (Pubitemid 37279631)
103. Prentoe, J. et al. (2011) Hypervariable region 1 differentially impacts viability of hepatitis C genotype 1-6 strains and impairs virus neutralization. Journal of Virology 85, 2224-2234
104. Forns, X. et al. (2000) Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proceedings of the National Academy of Sciences of the United States of America 97, 13318-13323
105. Voisset, C. et al. (2006) High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. Journal of General Virology 87, 2577-2581
106. Farci, P. et al. (1996) Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proceedings of the National Academy of Sciences of the United States of America 93, 15394-15399
107. Nieland, T.J. et al. (2002) Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proceedings of the National Academy of Sciences of the United States of America 99, 15422-15427 (Pubitemid 35403950)
108. Krieger, S.E. et al. (2010) Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Hepatology 51, 1144-1157
109. Harris, H.J. et al. (2008) CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. Journal of Virology 82, 5007-5020 (Pubitemid 351657061)
110. Harder, C.J. et al. (2006) Hepatic SR-BI-mediated cholesteryl ester selective uptake occurs with unaltered efficiency in the absence of cellular energy. Journal of Lipid Research 47, 492-503 (Pubitemid 43345590)
111. Wustner, D. et al. (2004) Different transport routes for high density lipoprotein and its associated free sterol in polarized hepatic cells. Journal of Lipid Research 45, 427-437 (Pubitemid 38337989)
112. Eckhardt, E.R. et al. (2004) High density lipoprotein uptake by scavenger receptor SR-BII. Journal of Biological Chemistry 279, 14372-14381 (Pubitemid 38468979)
113. Eckhardt, E.R. et al. (2006) High density lipoprotein endocytosis by scavenger receptor SR-BII is clathrin-dependent and requires a carboxylterminal dileucine motif. Journal of Biological Chemistry 281, 4348-4353 (Pubitemid 43847866)
114. Schwarz, A.K. et al. (2009) Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization. Journal of Virology 83, 12407-12414
115. Ikemoto, M. et al. (2000) Identification of a PDZdomain- containing protein that interacts with the scavenger receptor class B type I. Proceedings of the National Academy of Sciences of the United States of America 97, 6538-6543 (Pubitemid 30412749)
116. Komori, H. et al. (2008) Coexpression of CLA-1 and human PDZK1 in murine liver modulates HDL cholesterol metabolism. Arteriosclerosis, Thrombosis and Vascular Biology 28, 1298-1303
117. Eyre, N.S., Drummer, H.E. and Beard, M.R. (2010) The SR-BI partner PDZK1 facilitates hepatitis C virus entry. PLoS Pathogens 6, e101130.
118. Gu, X. et al. (1998) The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. Journal of Biological Chemistry 273, 26338-26348 (Pubitemid 28471637)
119. Rhainds, D. et al. (2004) Localization and regulation of SR-BI in membrane rafts of HepG2 cells. Journal of Cell Science 117, 3095-3105 (Pubitemid 39139897)
120. Babitt, J. et al. (1997) Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. Journal of Biological Chemistry 272, 13242-13249 (Pubitemid 27216752)
121. Subbaiah, P.V., Gesquiere, L.R. andWang, K. (2005) Regulation of the selective uptake of cholesteryl esters from high density lipoproteins by sphingomyelin. Journal of Lipid Research 46, 2699-2705 (Pubitemid 43107482)
122. Marsh, M. and Helenius, A. (2006) Virus entry: open sesame. Cell 124, 729-740 (Pubitemid 43261448)
123. Haid, S., Pietschmann, T. and Pecheur, E.I. (2009) Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles. Journal of Biological Chemistry 284, 17657-17667
124. Stiasny, K. and Heinz, F.X. (2004) Effect of membrane curvature-modifying lipids on membrane fusion by tick-borne encephalitis virus. Journal of Virology 78, 8536-8542 (Pubitemid 39025119)
125. Umashankar, M. et al. (2008) Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. Journal of Virology 82, 9245-9253
126. Rawat, S.S. et al. (2003) Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Molecular Membrane Biology 20, 243-254 (Pubitemid 37046249)
127. Wustner, D. (2005)Mathematical analysis of hepatic high density lipoprotein transport based on quantitative imaging data. Journal of Biological Chemistry 280, 6766-6779 (Pubitemid 40341232)
128. Charrin, S. et al. (2009) Lateral organization of membrane proteins: tetraspanins spin their web. Biochemical Journal 420, 133-154
129. Yalaoui, S. et al. (2008) Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection. Cell Host and Microbe 4, 283-292
130. Rodrigues, C.D. et al. (2008) Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host and Microbe 4, 271-282
131. Reaven, E. et al. (2004) Dimerization of the scavenger receptor class B type I: formation, function, and localization in diverse cells and tissues. Journal of Lipid Research 45, 513-528 (Pubitemid 38337998)
132. Cohn, J.S. et al. (2002) Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects. Journal of Lipid Research 43, 1680-1687 (Pubitemid 35168282)
133. Malmendier, C.L. et al. (1986) Metabolism of apolipoprotein C-I in normolipoproteinemic human subjects. Atherosclerosis 62, 167-172 (Pubitemid 16004148)
134. Gillotte, K.L. et al. (1999) Apolipoproteinmediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. Journal of Biological Chemistry 274, 2021-2028
135. Segrest, J.P. et al. (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. Journal of Lipid Research 33, 141-166
136. Munoz-Barroso, I. et al. (1999) Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. Journal of Virology 73, 6089-6092 (Pubitemid 29274898)
137. Salzwedel, K., West, J.T. and Hunter, E. (1999) A conserved tryptophan-rich motif in the membraneproximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Envmediated fusion and virus infectivity. Journal of Virology 73, 2469-2480 (Pubitemid 29098154)
138. Schibli, D.J., Montelaro, R.C. and Vogel, H.J. (2001) The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles. Biochemistry 40, 9570-9578 (Pubitemid 32757895)
139. Saez-Cirion, A. et al. (2003) Structural and functional roles of HIV-1 gp41 pretransmembrane sequence segmentation. Biophysical Journal 85, 3769-3780 (Pubitemid 37490287)
140. Shimizu, Y.K. et al. (1996) A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.Virology 223, 409-412 (Pubitemid 26319606)
141. Penin, F. et al. (2001) Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. Journal of Virology 75, 5703-5710 (Pubitemid 32488166)
142. Callens, N. et al. (2005) Basic residues in hypervariable region 1 of hepatitisCvirus envelope glycoprotein e2 contribute to virus entry. Journal of Virology 79, 15331-15341 (Pubitemid 43032315)
143. Tao, W. et al. (2009) A single point mutation in E2 enhances hepatitis C virus infectivity and alterslipoprotein association of viral particles. Virology 395, 67-76
144. von Hahn, T. et al. (2007) Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132, 667-678
145. Bartosch, B. et al. (2003) In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proceedings of theNational Academyof Sciences of the United States of America 100, 14199-14204 (Pubitemid 37499214)
146. Vieyres, G., Dubuisson, J. and Patel, A.H. (2010) Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein. Journal of General Virology
147. Farci, P. et al. (2000) The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-344 (Pubitemid 30226196)
148. Kato, N. et al. (1994) Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. Journal of Virology 68, 4776-4784 (Pubitemid 24226542)
149. Liu, L. et al. (2010) Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection. Journal of Virology 84, 5067-5077
150. van Doorn, L.J. et al. (1995) Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. Journal of Virology 69, 773-778
151. Booth, J.C. et al. (1998) Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 27, 223-227 (Pubitemid 28041558)
152. Ray, S.C. et al. (1999) Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. Journal of Virology 73, 2938-2946 (Pubitemid 29135682)
153. Mondelli, M.U. et al. (2001) Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain? Antiviral Research 52, 153-159 (Pubitemid 32973690)
154. Thomssen, R. et al. (1992) Association of hepatitis C virus in human sera with betalipoprotein. Medical Microbiology and Immunology (Berlin) 181, 293-300
155. Choo, S.-H. et al. (1995) Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection. Journal of General Virology 76, 2337-2341
156. Thomssen, R., Bonk, S. and Thiele, A. (1993) Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Medical Microbiology and Immunology (Berlin) 182, 329-334 (Pubitemid 24011208)
157. Lavillette, D. et al. (2005) Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. Journal of Virology 79, 6023-6034
158. Dreux, M. and Cosset, F.-L. (2007) The scavenger receptor BI and its ligand, HDL: partners in crime against HCV neutralising antibodies. Journal of viral Hepatitis 14 (Suppl 1), 68-76 (Pubitemid 47624116)
159. Roccasecca, R. et al. (2003) Binding of the hepatitis virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. Journal of Virology 77, 1856-1867 (Pubitemid 36109998)
160. Wyatt, R. and Sodroski, J. (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280, 1884-1888 (Pubitemid 28299385)
161. Masson, D. et al. (2009) Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor. Arteriosclerosis, Thrombosis and Vascular Biology 29, 2054-2060
162. Syder, A.J. et al. (2011) Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. Journal of Hepatology 54, 48-55
163. vonHahn, T. et al. (2006) Oxidized low density lipoprotein inhibits hepatitis C virus cell entry. Hepatology 43, 932-942
164. Baranova, I.N. et al. (2005) Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. Journal of Biological Chemistry 280, 8031-8040 (Pubitemid 40349701)
165. Cai, L. et al. (2005) Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. Journal of Biological Chemistry 280, 2954-2961 (Pubitemid 40189405)
166. Uhlar, C.M. and Whitehead, A.S. (1999) Serum amyloidA, the major vertebrate acute-phase reactant. European Journal of Biochemistry 265, 501-523 (Pubitemid 29488982)
167. Cai, Z. et al. (2007) Human serum amyloid A protein inhibits hepatitis C virus entry into cells. Journal of Virology 81, 6128-6133 (Pubitemid 46847050)
168. Lavie, M. et al. (2006) Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system. Hepatology 44, 1626-1634 (Pubitemid 44953668)
169. Puntoriero, G. et al. (1998) Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO Journal 17, 3521-3533 (Pubitemid 28327371)
170. Zucchelli, S. et al. (2001) Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization. Hepatology 33, 692-703 (Pubitemid 32185232)